Cargando…
Alterations of redox and iron metabolism accompany the development of HIV latency
HIV‐1 persists in a latent form during antiretroviral therapy, mainly in CD4(+) T cells, thus hampering efforts for a cure. HIV‐1 infection is accompanied by metabolic alterations, such as oxidative stress, but the effect of cellular antioxidant responses on viral replication and latency is unknown....
Autores principales: | Shytaj, Iart Luca, Lucic, Bojana, Forcato, Mattia, Penzo, Carlotta, Billingsley, James, Laketa, Vibor, Bosinger, Steven, Stanic, Mia, Gregoretti, Francesco, Antonelli, Laura, Oliva, Gennaro, Frese, Christian K, Trifunovic, Aleksandra, Galy, Bruno, Eibl, Clarissa, Silvestri, Guido, Bicciato, Silvio, Savarino, Andrea, Lusic, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196916/ https://www.ncbi.nlm.nih.gov/pubmed/32157726 http://dx.doi.org/10.15252/embj.2019102209 |
Ejemplares similares
-
Glycolysis downregulation is a hallmark of HIV‐1 latency and sensitizes infected cells to oxidative stress
por: Shytaj, Iart Luca, et al.
Publicado: (2021) -
HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells
por: Müller, Thorsten G, et al.
Publicado: (2021) -
A cure for AIDS: a matter of timing?
por: Shytaj, Iart Luca, et al.
Publicado: (2013) -
Chloroquine and beyond: exploring anti-rheumatic drugs to reduce immune hyperactivation in HIV/AIDS
por: Savarino, Andrea, et al.
Publicado: (2015) -
A scalable workflow to test “shock and kill” therapeutic approaches against the HIV-1 latent reservoir in blood cells ex vivo
por: Procopio, Francesco Andrea, et al.
Publicado: (2023)